Projects

According to animal studies, SHJ002 exerts an excellent effect in promoting corneal repair. To further confirm such an effect, a Phase-2 clinical trial has been conducted to evaluate the efficacy of SHJ002 in corneal erosion in patients with Sjogren’s syndrome. The primary endpoint is the improvement of corneal fluorescein stain judged by the NEI score.